Nutex Health NUTX 深 沪
等待开盘 08-24 09:30:00 美东时间
185.84
-2.700
-1.43%
华盛通- 最 高190.49
- 今 开189.40
- 成交量 11.49万股
- 最 低 185.00
- 昨 收 188.54
- 总市值 12.73亿
- 52周最高 204.00
- 市盈率 静 17.74
- 换手率 1.68%
- 52周最低 77.21
- 委 比 1.26%
- 总股本 684.80万
- 历史最高 7920.00
- 量 比 0.94
- 振 幅 2.91%
- 历史最低 11.25
- 每 手 1
- 风险率 31.41%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多NUTEX HEALTH OPENS WEST LITTLE ROCK EMERGENCY HOSPITAL IN ARKANSAS
HOUSTON, Aug. 18, 2026 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 28 state-of-the...
08-18 17:30
美股大行评级 | 潜在涨幅207.38%！Truist Securities上调AbCellera Biologics目标价至30美元，维持"买入"评级
今日重点评级关注：Truist Securities：维持AbCellera Biologics"买入"评级，目标价从12美元升至30美元；Stifel：维持Proficient Auto Logistics"买入"评级，目标价从9美元升至12美元
08-12 08:45
Lake Street Maintains Buy on Nutex Health, Raises Price Target to $310
Lake Street analyst Ben Haynor maintains Nutex Health (NASDAQ:NUTX) with a Buy and raises the price target from $235 to $310.
08-12 02:55
美股牛股 | BWNM飙升55%，获私募巨头溢价近6成收购；获华尔街投行齐声看多，STDN劲升35%；医药股ABCL大涨34%
BWNM飙升55%，获私募巨头溢价近6成收购；STDN劲升35%，机构称其在三结构各向同性核燃料市场中；医药股ABCL升超34%，潮热治疗药物中期试验效果积极>>
08-11 15:48
Nutex Health Q2 EPS $9.38 Beats $4.95 Estimate, Sales $210.752M Miss $215.031M Estimate
Nutex Health (NASDAQ:NUTX) reported quarterly earnings of $9.38 per share which beat the analyst consensus estimate of $4.95 by 89.49 percent. This is a 417.97 percent increase over losses of $(2.95) per share from the same period last year. The company reported quarterly sales of $210.752 million w...
08-07 04:48
Clinigence Holdings Revises Dispute Resolution Services Agreement
Clinigence Holdings ( ($NUTX) ) has provided an announcement. Effective June 30...
07-22 05:49
美股夜盘 | Delek Us控股涨11.84%，SharonAI Holdings, Inc. Class A涨9.70%
Delek Us控股涨11.84%；SharonAI Holdings, Inc. Class A涨9.70%；Primoris服务涨9.54%
07-06 10:01
美股夜盘 | Delek Us控股涨11.84%，SharonAI Holdings, Inc. Class A涨11.49%
Delek Us控股涨11.84%；SharonAI Holdings, Inc. Class A涨11.49%；Primoris服务涨9.54%
07-06 09:01
美股大行评级 | 潜在涨幅90.66%！Tango Therapeutics获杰富瑞升目标价至60美元，上调至"买入"评级
今日重点评级关注：杰富瑞：上调Tango Therapeutics评级至"买入"，目标价从27美元升至60美元；Susquehanna：维持安森美半导体"积极"评级，目标价从120美元升至140美元
06-29 15:49
